#208 Robot Assisted Simple Prostatectomy with Hugo RAS system Dr. Adele Piro

This is one of the 2023 KS International Innovation Awards videos selected for inclusion in the Vattikuti Foundation – ORSI Humans on the Cutting Edge of Robotic Surgery Conference, October 6, 7 & 8, 2023 in Ghent, Belgium. Posting does not imply that is has been selected as a Finalist, just that the content will be discussed at the Conference.

From the entry: RASP with Hugo RAS system: two different techniques.

Introduction Limited clinical data exist for non-oncological procedures with HugoTM robot-assisted surgery (RAS) system. Robot-assisted simple prostatectomy (RASP) is a minimally invasive option for benign prostatic hyperplasia, with comparable early functional outcomes and better peri-operative results than open simple prostatectomy. We present the first large series of RASP performed using the HugoTM RAS system.

Methods This video describes two techniques for RASP and reports the analysis of 20 consecutive patients who underwent the procedure at OLV Hospital (Belgium) from February 2022 to March 2023. Patient characteristics, perioperative details, pathological findings, and one-month functional outcomes were recorded using median (interquartile range [IQR]) and frequencies.

Results Median age (IQR) and preoperative PSA were 72 (67 – 76) years and 7.7 (5.0 – 13.4) ng/ml, respectively. 11 patients experienced preoperative acute urinary retention, and 8 had indwelling bladder catheters before surgery. No intraoperative complications occurred. Median operative and console times were 165 (121 – 180) and 125 (101 – 148) minutes, respectively. 80% of patients had their urethral catheters removed on the first postoperative day. Median hospital stay was 3 (3 – 4) days. On final pathology, median prostate volume was 120 (101-154) grams. Post-operative uroflowmetry revealed median Qmax and post-void residual (PVR) of 16 (13 – 26) ml/s and 15 (0 – 34) cc, respectively.

Conclusions This series presents the initial surgical outcomes of RASP using the HugoTM RAS System. Although longer follow-up is needed, our study suggests that the HugoTM RAS system has diverse applications and can deliver optimal outcomes in non-oncological procedures.

See more at: https://vattikutifoundation.com/videos/